The deal size was raised to $175M in common stock and prefunded warrants from $125M and priced within the $14.50-$15.50 range. JPMorgan, Piper Sandler and Stifel acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRIX:
- Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
- Nurix Therapeutics Announces Proposed Public Offering
- Nurix Therapeutics price target raised to $23 from $22 at RBC Capital
- 3 Best Stocks to Buy Now, 4/11/2024, According to Top Analysts
- Nurix Therapeutics price target raised to $25 from $24 at Baird
